Increases in methamphetamine injection among treatment admissions in the U.S
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields



Publication Date Range:


Document Data


Document Type:






Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

Increases in methamphetamine injection among treatment admissions in the U.S

Public Access Version Available on: January 01, 2024, 12:00 AM
Please check back on the date listed above.
  • English

  • Details:

    • Alternative Title:
      Addict Behav
    • Description:

      Prior research indicates rising methamphetamine use and harms in the U.S., potentially related to increases in methamphetamine injection. To date, research on trends and correlates of methamphetamine injection is limited.


      Analysis of trends and correlates of methamphetamine injection among treatment admissions among persons aged ≥ 12 whose primary substance of use at admission is methamphetamine. Data are from the Treatment Episode Data Set. Analyses includes descriptive statistics, trend analyses, and multilevel multivariable logistic regression.


      Primary methamphetamine treatment admissions increased from 138,379 in 2010 to 201,021 in 2019. Among primary methamphetamine admissions, injection as the usual route of use increased from 24,821 (18.0% of admissions) in 2010 to 55,951 (28.2% of admissions) in 2019. Characteristics associated with increased adjusted odds of reporting methamphetamine injection included: males (aOR=1.13, 95% CI=1.10–1.15); admission age 25–34 years (aOR= 1.23, 95% CI=1.19–1.28) and 35–44 years (aOR=1.12, 95% CI=1.08–1.17) compared to age 18–24; dependent living (aOR=1.33, 95% CI=1.29–1.37) and homelessness (aOR=1.58, 95% CI=1.54–1.63) compared to independent living; part-time employment (aOR=1.08, 95% CI=1.02–1.14), unemployment (aOR=1.39, 95% CI=1.34–1.44) and not in labor force (aOR=1.43, 95% CI=1.37–1.49) compared to full-time employment; one to ≥four prior treatment admissions (aORs ranging from 1.19 to 1.94) compared to no prior admissions; also reporting use of cocaine (aOR=1.10, 95% CI=1.05–1.16), heroin (aOR=3.52, 95% CI=3.40–3.66), prescription opioids (aOR=1.61, 95% CI=1.54–1.67), or benzodiazepines (aOR=1.42, 95% CI=1.32–1.52) at treatment admission.


      Findings lend further evidence to a resurgence of methamphetamine use that is intertwined with the ongoing opioid crisis in the U.S. Efforts to expand evidence-based prevention, treatment, and response efforts, particularly to populations at highest risk, are urgently needed.

    • Pubmed ID:
    • Pubmed Central ID:
    • Document Type:
    • Place as Subject:
    • Collection(s):
    • Main Document Checksum:
    • File Type:
    • Supporting Files:
      No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at